Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

- PMLiVE

NICE set to back Novartis’ Xolair for skin condition CSU

Issues final draft guidance on the treatment's use as an add-on for chronic spontaneous urticaria

- PMLiVE

Adaptimmune appoints Lawrence Alleva to its board

The former PwC partner will also chair its boardaudit committee

- PMLiVE

FDA clears first therapy for rare childhood cancer

United Therapeutics’ Unituxin approved for neuroblastoma

- PMLiVE

NICE gives nod to blood cancer drug Gazyvaro

Roche’s leukaemia drug to be used in combination with chemotherapy

- PMLiVE

Novo’s Tresiba reduces risk of hypoglycaemia

New clinical data on the diabetes drug also shows blood glucose control benefits

- PMLiVE

Hepatitis C drugs drive US drug costs up in 2014

Played a role in a 13% increase in US prescription spending

- PMLiVE

Quality in Care’s 2015 diabetes programme launches at Diabetes UK

Now open for entries to celebrate best practice in NHS diabetes care

- PMLiVE

23andMe names privacy officer and corporate counsel

Kate Black joins from the US Department of Health and Human Services

- PMLiVE

KCR relocates head office from Warsaw to Berlin

Polish contract research organisation opens newbase in Germany

Choices, choices: the rapidly evolving HIV treatment landscape

The treatment options for HIV in Europe has seen some revolutionary changes

- PMLiVE

Making the right mobile health choices

Creative thinking is one of the requirements to ensure lasting healthcare change

- PMLiVE

Responding to non-adherence

It's a complex exercise, but strategies must begin and end with the patient

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links